Menu

• Ask a Health Expert about CONGENITAL BLADDER ANOMALY
• Post Your Side Effect related to CONGENITAL BLADDER ANOMALY
• CONGENITAL BLADDER ANOMALY and FDA Warnings
• CONGENITAL BLADDER ANOMALY in Patients Wiki
• Report CONGENITAL BLADDER ANOMALY in Drug Side Effect Survey

CONGENITAL BLADDER ANOMALY side effect

What is CONGENITAL BLADDER ANOMALY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prograf Side Effects Report #5650628-6
Health Professional from FRANCE reported PROGRAF problem on Feb 15, 2008. Male patient was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: congenital bladder anomaly, renal hypoplasia, urethral valves, . PROGRAF dosage: 7 MG, D, TRANSPLACENTAL. During the same period patient was treated with AZATHIOPRINE, ASPEGIC, PREDNISOLONE, SPECIAFOLDINE. Patient died on 10/18/2007.

Prograf Side Effects Report #5650675-4
PROGRAF problem was reported by a Health Professional from FRANCE on Feb 15, 2008. Female patient was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: congenital bladder anomaly, congenital nose malformation, ear malformation, endometritis decidual, oligohydramnios, placental disorder, pregnancy, renal hypoplasia, . PROGRAF dosage: 7 MG, D, ORAL. During the same period patient was treated with AZATHIOPRINE, ASPEGIC, PREDNISOLONE, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5675838-3
Health Professional from CANADA reported REMICADE problem on Mar 12, 2008. Female patient was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: congenital bladder anomaly, gastroschisis, . REMICADE dosage: (DOSE POSSIBLY 300 MG). During the same period patient was treated with PURINETHOL. Patient recovered.

Depakene Side Effects Report #5384123-9
DEPAKENE problem was reported by a Health Professional from FRANCE on July 02, 2007. Male patient, weighting 8.60 lb, was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: congenital bladder anomaly, hydronephrosis, hypotonia neonatal, inguinal hernia, psychomotor skills impaired, pyloric stenosis, . DEPAKENE dosage: unknown. Patient recovered.


Depakene Side Effects Report #5384123-9
Health Professional from FRANCE reported DEPAKENE problem on July 02, 2007. Male patient, weighting 8.60 lb, was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: congenital bladder anomaly, hydronephrosis, hypotonia neonatal, inguinal hernia, psychomotor skills impaired, pyloric stenosis, . DEPAKENE dosage: unknown. Patient recovered.

Remicade Side Effects Report #5759362-5
REMICADE problem was reported by a Health Professional from CANADA on May 27, 2008. Female patient was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: congenital bladder anomaly, gastroschisis, . REMICADE dosage: (DOSE POSSIBLY 300 MG). During the same period patient was treated with PURINETHOL. Patient recovered.

Rebif Side Effects Report #5705091-3
Consumer or non-health professional from UNITED STATES reported REBIF problem on Mar 31, 2008. Female patient, weighting 6.40 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: congenital bladder anomaly, cystitis, dehydration, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5670722-3
GLEEVEC problem was reported by a Physician from DENMARK on Mar 07, 2008. Female patient, 23 years of age, was diagnosed with chronic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital bladder anomaly, congenital hydronephrosis, urethral valves, . GLEEVEC dosage: unknown. Patient recovered.

Gleevec Side Effects Report #5619827-3
Physician from DENMARK reported GLEEVEC problem on Jan 28, 2008. Female patient, 23 years of age, was diagnosed with chronic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital bladder anomaly, congenital hydronephrosis, urethral valves, . GLEEVEC dosage: unknown. Patient recovered.


Gleevec Side Effects Report #5620311-1
GLEEVEC problem was reported by a Physician from DENMARK on Feb 04, 2008. Female patient, 23 years of age, was diagnosed with chronic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital bladder anomaly, congenital hydronephrosis, urethral valves, . GLEEVEC dosage: unknown. Patient recovered.

Gleevec Side Effects Report #5626027-X
Physician from DENMARK reported GLEEVEC problem on Feb 04, 2008. Female patient, 23 years of age, was diagnosed with chronic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital bladder anomaly, congenital hydronephrosis, urethral valves, . GLEEVEC dosage: unknown. Patient recovered.

Prograf Side Effects Report #5635681-8
PROGRAF problem was reported by a Health Professional from FRANCE on Dec 10, 2007. Male patient, weighting 0.44 lb, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital bladder anomaly, congenital cardiovascular anomaly, oligohydramnios, renal hypoplasia, urethral valves, . PROGRAF dosage: 7 MG, /D, TRANSPLACENTAL. During the same period patient was treated with AZATHIOPRINE, ASPEGIC, PREDNISOLONE, SPECIAFOLDINE. Patient died on 10/18/2007.

Peginteron Side Effects Report #5636458-X
Physician from DENMARK reported PEGINTERON problem on Feb 11, 2008. Male patient was treated with PEGINTERON. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital bladder anomaly, congenital hydronephrosis, . PEGINTERON dosage: unknown. Patient recovered.

Rivotril Side Effects Report #5637375-1
RIVOTRIL problem was reported by a Physician from FRANCE on Feb 11, 2008. Female patient, 24 years of age, was diagnosed with pain and was treated with RIVOTRIL. After drug was administered, patient experienced the following problems/side effects: caudal regression syndrome, congenital bladder anomaly, . RIVOTRIL dosage: unknown. During the same period patient was treated with LYSANXIA, PAROXETINE, LEPTICUR, LARGACTIL, SULFARLEM, DAFALGAN, SUBUTEX. Patient recovered.


Alteis Side Effects Report #5706335-4
Consumer or non-health professional from FRANCE reported ALTEIS problem on Mar 27, 2008. Male patient, weighting 1.79 lb, was diagnosed with hypertension and was treated with ALTEIS. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital bladder anomaly, congenital central nervous system anomaly, foetal growth retardation, multiple congenital abnormalities, oligohydramnios, potter's syndrome, . ALTEIS dosage: unknown. During the same period patient was treated with LODOZ. Patient died on 01/01/2008.

Lodoz Side Effects Report #5712116-8
LODOZ problem was reported by a Consumer or non-health professional from FRANCE on Mar 28, 2008. Male patient was treated with LODOZ. After drug was administered, patient experienced the following problems/side effects: cerebral hypoperfusion, congenital bladder anomaly, congenital central nervous system anomaly, foetal disorder, foetal growth retardation, multiple congenital abnormalities, potter's syndrome, . LODOZ dosage: unknown. During the same period patient was treated with OLMESARTAN MEDOXOMIL. Patient was hospitalized. Patient died.

Lamictal Side Effects Report #5690824-5
Consumer or non-health professional from FRANCE reported LAMICTAL problem on Mar 21, 2008. Male patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: anomaly of external ear congenital, arthropathy, congenital bladder anomaly, congenital hand malformation, congenital nose malformation, dandy-walker syndrome, dysmorphism, hypertelorism of orbit, . LAMICTAL dosage: 50MG TWICE PER DAY. Patient died on 11/20/2007.

Alteis Side Effects Report #5706332-9
ALTEIS problem was reported by a Consumer or non-health professional from FRANCE on Mar 27, 2008. Male patient, weighting 1.79 lb, was diagnosed with hypertension and was treated with ALTEIS. After drug was administered, patient experienced the following problems/side effects: abortion induced, brain malformation, congenital bladder anomaly, growth retardation, multiple congenital abnormalities, oligohydramnios, potter's syndrome, pulmonary hypoplasia, . ALTEIS dosage: unknown. During the same period patient was treated with LODOZ. Patient died on 01/01/2008.

Prograf Side Effects Report #5713726-4
Health Professional from FRANCE reported PROGRAF problem on Apr 03, 2008. Male patient was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abortion induced, congenital bladder anomaly, congenital hand malformation, congenital nose malformation, congenital ureteric anomaly, ear malformation, micrognathia, . PROGRAF dosage: 7 MG, TRANSPLACENTAL. During the same period patient was treated with AZATHIOPRINE, ASPEGIC, PREDNISOLONE. Patient died on 10/18/2007.


Prograf Side Effects Report #5724858-9
PROGRAF problem was reported by a Health Professional from FRANCE on Apr 11, 2008. Male patient was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital anomaly, congenital bladder anomaly, congenital hand malformation, congenital nose malformation, ear malformation, micrognathia, renal hypoplasia, . PROGRAF dosage: 7 MG, D, TRANSPLACENTAL. During the same period patient was treated with AZATHIOPRINE, ASPEGIC, PREDNISOLONE, FOLIC ACID. Patient died on 10/18/2007.